Published in Cochrane Database Syst Rev on March 14, 2012
Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol (2014) 1.26
Future directions for the early detection of colorectal cancer recurrence. J Cancer (2014) 1.05
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer (2013) 0.97
Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol (2015) 0.96
Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol (2014) 0.90
Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol (2015) 0.88
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. Int J Cancer (2014) 0.86
Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst (2015) 0.85
A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer. Int J Colorectal Dis (2014) 0.83
Folate levels measured by LC-MS/MS in patients with colorectal cancer treated with different leucovorin dosages. Cancer Chemother Pharmacol (2014) 0.82
Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades. BMC Cancer (2014) 0.82
The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol (2015) 0.81
The emerging role of neoadjuvant chemotherapy for rectal cancer. J Gastrointest Oncol (2014) 0.80
Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Ann R Coll Surg Engl (2014) 0.79
Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers. PLoS One (2014) 0.79
Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer. BMC Cancer (2015) 0.78
High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome. Am J Cancer Res (2015) 0.78
Update on advances and controversy in rectal cancer treatment. Tech Coloproctol (2016) 0.78
Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy. J Geriatr Oncol (2016) 0.77
Current debate in the oncologic management of rectal cancer. World J Gastrointest Oncol (2016) 0.77
Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial. J Am Coll Surg (2015) 0.76
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget (2016) 0.76
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: a systematic review. World J Gastroenterol (2014) 0.76
Adjuvant chemotherapy. EJC Suppl (2013) 0.76
Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis. World J Surg (2016) 0.75
[Rectal cancer: improved prognosis with postoperative chemotherapy?]. Dtsch Med Wochenschr (2013) 0.75
Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease. Int Sch Res Notices (2015) 0.75
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol (2015) 0.75
Adjuvant chemotherapy for rectal cancer: Is it needed? World J Clin Oncol (2015) 0.75
On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci (2017) 0.75
Pre- and post-surgery treatments in rectal cancer: a long-term single-centre experience. Curr Oncol (2017) 0.75
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model. Oncotarget (2016) 0.75
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer. PLoS One (2012) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer. Oncotarget (2015) 0.75
Progress in rectal cancer treatment. ISRN Gastroenterol (2012) 0.75
Characteristics affecting survival after locally advanced colorectal cancer in Quebec. Curr Oncol (2015) 0.75
Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study. Int J Colorectal Dis (2015) 0.75
Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy. Clin Transl Oncol (2017) 0.75
A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study. Int J Colorectal Dis (2015) 0.75
Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study. World J Surg (2016) 0.75
Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database. Langenbecks Arch Surg (2016) 0.75
Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg (2014) 3.80
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol (2012) 3.26
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol (2009) 2.64
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res (2002) 2.21
Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev (2012) 1.91
Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev (2011) 1.82
Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer (2003) 1.77
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat (2012) 1.77
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol (2003) 1.75
Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol (2011) 1.69
Hospital variation in 30-day mortality after colorectal cancer surgery in denmark: the contribution of hospital volume and patient characteristics. Ann Surg (2011) 1.68
Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev (2012) 1.68
Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol (2008) 1.65
[Perioperative thrombosis prophylaxis--where are we going?]. Ugeskr Laeger (2005) 1.58
Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. Ann Surg Oncol (2004) 1.55
The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med (2006) 1.53
Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum (2004) 1.45
Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev (2012) 1.45
Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg (2005) 1.42
Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell Melanoma Res (2013) 1.41
[Follow-up of patients after radical surgery for colorectal cancer]. Ugeskr Laeger (2005) 1.39
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics (2013) 1.39
Open or laparoscopic appendicectomy? Colorectal Dis (2009) 1.38
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol (2009) 1.36
Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev (2009) 1.34
Complementary techniques: validation of gene expression data by quantitative real time PCR. Adv Exp Med Biol (2007) 1.32
Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. J Immunother (2002) 1.17
Do patient characteristics, disease, or treatment explain social inequality in survival from colorectal cancer? Soc Sci Med (2009) 1.17
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev (2009) 1.17
Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res (2002) 1.14
A gene expression signature associated with survival in metastatic melanoma. J Transl Med (2006) 1.13
Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol (2006) 1.12
The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem (2010) 1.08
Tumor necrosis factor (TNF) biology and cell death. Front Biosci (2008) 1.07
Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer (2009) 1.04
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med (2003) 1.01
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am (2003) 1.00
Indeterminate pulmonary nodules at colorectal cancer staging: a systematic review of predictive parameters for malignancy. Ann Surg Oncol (2013) 0.99
Suppressive influences in the immune response to cancer. J Immunother (2009) 0.99
Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med (2009) 0.99
Cancer vaccines: pessimism in check. Nat Med (2004) 0.97
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum Gene Ther (2006) 0.95
The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol (2003) 0.92
MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts. Trends Mol Med (2006) 0.91
How do patients with colorectal cancer perceive treatment and care compared with the treating health care professionals? Med Care (2007) 0.90
The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele. Transfusion (2003) 0.89
Thromboembolic prophylaxis as a risk factor for postoperative complications after breast cancer surgery. World J Surg (2004) 0.89
Role of resection margins in patients treated with breast conservation surgery. Cancer (2008) 0.88
The transition between work, sickness absence and pension in a cohort of Danish colorectal cancer survivors. BMJ Open (2013) 0.88
Systematic review of thromboprophylaxis in colorectal surgery -- an update. Colorectal Dis (2005) 0.88
Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol (2008) 0.87
Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. Front Biosci (2005) 0.86
Association of Comorbidity with Anastomotic Leak, 30-day Mortality, and Length of Stay in Elective Surgery for Colonic Cancer: A Nationwide Cohort Study. Dis Colon Rectum (2015) 0.85
N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol (2007) 0.85
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis. Ann Surg (2017) 0.84
Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas. Ann Surg Oncol (2005) 0.82
[The completeness and quality of the Danish Colorectal Cancer clinical database on colorectal cancer]. Ugeskr Laeger (2004) 0.82
Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study. World J Surg (2014) 0.82
Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer. Scand J Gastroenterol (2007) 0.82
Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma. Suppl Tumori (2003) 0.82
Use of preoperative bowel preparation in elective colorectal surgery in Denmark remains high. Dan Med Bull (2011) 0.81
Strategies to enhance the anticancer potential of TNF. Front Biosci (2008) 0.81
Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol (2010) 0.81
Case-mix study of single incision laparoscopic surgery (SILS) vs. conventional laparoscopic surgery in colonic cancer resections. Pol Przegl Chir (2013) 0.80
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol (2014) 0.80
Single incision laparoscopic surgery: new 'toys for boys'? Colorectal Dis (2011) 0.80
Follow-up in colorectal cancer: questions to be answered. Colorectal Dis (2011) 0.79
Risk factors for mortality and postoperative complications after gastrointestinal surgery. J Gastrointest Surg (2007) 0.79
The melanoma molecular map project. Melanoma Res (2008) 0.79
Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178. Int J Cancer (2003) 0.79
Interventions for melanoma in situ, including lentigo maligna. Cochrane Database Syst Rev (2014) 0.79
Just another stoma - why have we not improved? Colorectal Dis (2010) 0.79
Preliminary results after single-port laparoscopic colonic surgery. Dan Med J (2012) 0.79
TNF-based isolated limb perfusion followed by consolidation biotherapy with systemic low-dose interferon alpha 2b in patients with in-transit melanoma metastases: a pilot trial. Ann Surg Oncol (2008) 0.78
Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol (2002) 0.78
TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends. J Immunother (2003) 0.78
Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy. Anticancer Res (2009) 0.78
Delayed ischemic cecal perforation despite optimal decompression after placement of a self-expanding metal stent: report of a case. Dis Colon Rectum (2004) 0.78
Circulating tumor cells in solid cancer: tumor marker of clinical relevance? Curr Oncol Rep (2008) 0.78
Indeterminate pulmonary nodules in colorectal-cancer: do radiologists agree? Ann Surg Oncol (2014) 0.78
Editorial: cancer chemoresistance and DNA repair. Curr Med Chem (2012) 0.77
Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis. Melanoma Res (2014) 0.77
Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases. Oncol Rep (2004) 0.77
Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. Anticancer Res (2010) 0.77
True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function. World J Surg (2004) 0.77
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma. Cochrane Database Syst Rev (2015) 0.77
Actual false-negative rate prompts the routine use of ultrasound scan before and after sentinel node biopsy in melanoma. Ann Surg Oncol (2008) 0.76
Acceptable results using plug for the treatment of complex anal fistulas. Dan Med Bull (2011) 0.76
Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am (2008) 0.76
Rectal metastasis from infiltrating lobular breast carcinoma: imaging with 18F-FDG PET. Eur Radiol (2004) 0.76
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Evidence-based guidelines? Dis Colon Rectum (2005) 0.75
Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy. J Transl Med (2004) 0.75
Reply to Letter: "Anastomotic Leak Increases Distant Recurrence and Long-term Mortality After Curative Resection for Colonic Cancer". Ann Surg (2015) 0.75
Laparoscopic surgery for Crohn's disease: a meta-analysis. Dis Colon Rectum (2007) 0.75
Reply to Letter: "Prospective Analysis of 8589 Patients With Colonic Cancer: Can We Conclude That Anastomotic Leak Is a Prognostic Factor?". Ann Surg (2016) 0.75